Copyright
©The Author(s) 2023.
World J Diabetes. Oct 15, 2023; 14(10): 1562-1572
Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1562
Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1562
Table 1 Background characteristics of patients with diabetes (n = 30) and subjects without diabetes (n = 10)
Characteristic | T1DM group | T2DM group | P value | Subjects without diabetes |
Days evaluated, n | 60 | 296 | - | 23 |
Age, yr | 50 (43-66) | 61 (48-71) | 0.419a | 60 (47.5-72.3) |
Sex as female/male, n | 2/3 | 7/18 | 0.622b | 4/6 |
BMI in kg/m2 | 28.3 (26.0-39.3) | 26.0 (22.5-28.6) | 0.229a | 22.9 (21.7-27.2) |
HbA1c, % | 8.8 (8.6-9.3) | 7.6 (6.9-9.0) | 0.220a | 5.4 (5.4-5.5) |
Log MG | 5.09 ± 0.32 | 5.11 ± 0.30 | 0.579c | 4.61 ± 0.08 |
SD | 56.26 ± 18.63 | 44.60 ± 20.29 | < 0.001c | 11.58 ± 2.37 |
%CV | 34.85 ± 11.85 | 25.53 ± 7.43 | < 0.001c | 11.56 ± 2.66 |
Log MAGE | 4.58 ± 0.40 | 4.41 ± 0.42 | 0.003c | 3.17 ± 0.27 |
Medication, n | ||||
Metformin | 0 | 5 | 0.556b | N/A |
DPP-4 inhibitor | 0 | 21 | 0.001b | N/A |
α-GI | 0 | 3 | 1.000b | N/A |
Thiazoline | 0 | 14 | 0.045b | N/A |
SGLT2 inhibitor | 0 | 4 | 1.000b | N/A |
SU | 0 | 0 | 1.000b | N/A |
GLP-1 RA | 0 | 5 | 0.556b | N/A |
Insulin | 5 | 16 | 0.286b | N/A |
Total insulin dose in U | 37 (34-38) | 8 (0-20) | 0.008a | N/A |
Ultra-rapid in U | 21 (18-26) | 0 (0-11) | 0.030a | N/A |
Lasting in U | 16 (11-20) | 2 (0-14) | 0.022a | N/A |
Table 2 Prevalence rate of emerging items on the contour map treated by a continuous wavelet transform between the type 1 diabetes mellitus and type 2 diabetes mellitus groups, n = 356
Time zone | Position | Frequency zone | Prevalence rate, % | ||
T1DM group | T2DM group | P value | |||
Midnight | |||||
P9 | Super-high | 20 | 7 | 0.003 | |
P1 | High | 85 | 88 | 0.527 | |
P4 | Middle | 20 | 34 | 0.047 | |
P12 | Low | 13 | 26 | 0.032 | |
P13 | Low | 15 | 32 | 0.008 | |
Daytime | |||||
P10 | Super-high | 27 | 11 | 0.003 | |
P2 | High | 88 | 93 | 0.299 | |
P5 | Middle | 32 | 39 | 0.311 | |
P6 | Middle | 40 | 43 | 0.670 | |
P7 | Middle | 42 | 48 | 0.478 | |
P14 | Low | 15 | 33 | 0.005 | |
P15 | Low | 15 | 35 | 0.001 | |
Night | |||||
P11 | Super-high | 13 | 10 | 0.491 | |
P3 | High | 83 | 94 | 0.014 | |
P8 | Middle | 42 | 50 | 0.321 | |
P17 | Low | 25 | 43 | 0.014 | |
P18 | Low | 22 | 41 | 0.005 |
Table 3 Comparison of frequency on the contour map treated by a continuous wavelet transform between the type 1 diabetes mellitus and type 2 diabetes mellitus groups, n = 356
Time zone | Position | Frequency zone | T1DM group | T2DM group | P value | ||||
Min | Median | Max | Min | Median | Max | ||||
Midnight | |||||||||
P9 | Super-high | 106 | 108 | 108 | 106 | 107 | 108 | 0.433 | |
P1 | High | 61 | 75 | 85 | 61 | 73 | 80 | 0.006 | |
P4 | Middle | 39 | 45 | 53 | 38 | 45 | 56 | 0.265 | |
P12 | Low | 29 | 30.5 | 38 | 28 | 32 | 36 | 0.634 | |
P13 | Low | 29 | 30 | 36 | 27 | 31 | 35 | 0.965 | |
Daytime | |||||||||
P10 | Super-high | 106 | 108 | 108 | 106 | 107 | 108 | 0.100 | |
P2 | High | 66 | 75 | 84 | 59 | 74 | 81 | 0.088 | |
P5 | Middle | 37 | 45 | 50 | 37 | 44 | 51 | 0.418 | |
P6 | Middle | 33 | 45.5 | 58 | 37 | 44 | 51 | 0.005 | |
P7 | Middle | 35 | 45 | 54 | 33 | 44 | 57 | 0.225 | |
P14 | Low | 25 | 30 | 33 | 18 | 30 | 35 | 0.895 | |
P15 | Low | 25 | 30 | 32 | 17 | 30 | 37 | 0.885 | |
P16 | Low | 25 | 30.5 | 33 | 20 | 30 | 36 | 0.725 | |
Night | |||||||||
P11 | Super-high | 107 | 108 | 108 | 105 | 107 | 108 | 0.004 | |
P3 | High | 65 | 75 | 85 | 59 | 74 | 86 | 0.104 | |
P8 | Middle | 36 | 45 | 54 | 37 | 44 | 53 | 0.893 | |
P17 | Low | 25 | 28.5 | 33 | 17 | 29 | 36 | 0.395 | |
P18 | Low | 26 | 33 | 35 | 17 | 31 | 37 | 0.166 |
Table 4 Comparison of area on the contour map treated by a continuous wavelet transform between the type 1 diabetes mellitus and type 2 diabetes mellitus groups, n = 356
Time zone | Position | Frequency zone | T1DM group | T2DM group | P value | ||||
Min | Median | Max | Min | Median | Max | ||||
Midnight | |||||||||
P9 | Super-high | 0.00 | 0.00 | 8.70 | 0.00 | 0.00 | 5.34 | 0.008 | |
P1 | High | 0.00 | 3.01 | 8.99 | 0.00 | 2.75 | 8.14 | 0.866 | |
P4 | Middle | 0.00 | 0.00 | 5.06 | 0.00 | 0.00 | 5.67 | 0.111 | |
P12 | Low | 0.00 | 0.00 | 0.60 | 0.00 | 0.00 | 4.01 | 0.043 | |
P13 | Low | 0.00 | 0.00 | 0.65 | 0.00 | 0.00 | 1.83 | 0.011 | |
Daytime | |||||||||
P10 | Super-high | 0.00 | 0.00 | 8.32 | 0.00 | 0.00 | 6.81 | 0.001 | |
P2 | High | 0.00 | 3.96 | 5.87 | 0.00 | 3.65 | 6.43 | 0.267 | |
P5 | Middle | 0.00 | 0.00 | 3.32 | 0.00 | 0.00 | 5.23 | 0.249 | |
P6 | Middle | 0.00 | 0.00 | 5.77 | 0.00 | 0.00 | 3.70 | 0.812 | |
P7 | Middle | 0.00 | 0.00 | 5.29 | 0.00 | 0.00 | 5.50 | 0.348 | |
P14 | Low | 0.00 | 0.00 | 0.95 | 0.00 | 0.00 | 3.91 | 0.005 | |
P15 | Low | 0.00 | 0.00 | 1.42 | 0.00 | 0.00 | 4.40 | 0.003 | |
P16 | Low | 0.00 | 0.00 | 1.63 | 0.00 | 0.00 | 2.22 | 0.020 | |
Night | |||||||||
P11 | Super-high | 0.00 | 0.00 | 1.07 | 0.00 | 0.00 | 6.48 | 0.257 | |
P3 | High | 0.00 | 3.39 | 8.38 | 0.00 | 3.75 | 9.18 | 0.258 | |
P8 | Middle | 0.00 | 0.00 | 5.09 | 0.00 | 0.00 | 6.70 | 0.163 | |
P17 | Low | 0.00 | 0.00 | 2.02 | 0.00 | 0.00 | 2.47 | 0.031 | |
P18 | Low | 0.00 | 0.00 | 7.09 | 0.00 | 0.00 | 7.08 | 0.059 |
Table 5 Logistic regression analysis for the identification of characteristics of type 1 diabetes mellitus with selected factors, n = 356
Selected item | Odds ratio | 95%CI | P value | |
Lower | Upper | |||
Frequency of P1 signal | 1.33 | 1.08 | 1.62 | 0.006 |
Frequency of P6 signal | 0.84 | 0.63 | 1.12 | 0.232 |
Area of P10 signal | 1.24 | 0.72 | 2.14 | 0.432 |
Area of P17 signal | 1.24 | 0.29 | 5.29 | 0.771 |
- Citation: Nakamura Y, Furukawa S. Characteristics of glucose change in diabetes mellitus generalized through continuous wavelet transform processing: A preliminary study. World J Diabetes 2023; 14(10): 1562-1572
- URL: https://www.wjgnet.com/1948-9358/full/v14/i10/1562.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i10.1562